StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.07−0.05 (-1.60%)

Close on Nov 20, 2026Market cap $175.02MP/E –Yield –

Whitehawk Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Whitehawk Therapeutics's pe ratio was 19.3× on Jan 30, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 202619.3×+2.0
2025Dec 31, 202517.3×–

More Whitehawk Therapeutics figures

See a number that looks wrong?